fwreports.comFirstWord Reports Platform - Home
fwreports.com Profile
fwreports.com is a domain
that was created on 2009-10-13,making it 15 years ago.
It has several subdomains, such as eu.fwreports.com , among others.
Discover fwreports.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
fwreports.com Information
| HomePage size: 37.816 KB |
| Page Load Time: 0.881258 Seconds |
| Website IP Address: 104.18.19.181 |
fwreports.com Similar Website
| HRC Digital Reports |
| Stock Market Today : Reports, Quotes and News - MarketScreener |
| Consumer Reports Data Intelligence |
| Malware Removal, Windows Tips, Anti-Malware & Scam Reports — How To Fix Guide |
| Kavli Institute Pre-Print Publications |
| CentOS Blog |
| Ken Garff Reports |
| RUBF Fishing and Hunting Reports - RUBF, RUBF Fishing and Hunting Reports, BASS, FISHING, ICE FISHIN |
| Mueller Reports – Mueller Reports |
| LexisNexis Police Reports | Search Accident Reports |
| FirstWord Reports - Pharma and MedTech Intelligence |
| IPwe Reports & Advisory Services - IPwe Reports |
fwreports.com PopUrls
http://www.fwreports.com/ |
http://www.fwreports.com/firstview/ |
http://www.fwreports.com/therapy-trends/ |
http://www.fwreports.com/biosimilar-index/ |
https://www.fwreports.com/dossier/the-state-of-pharma-digital-transformation-2020/ |
http://www.fwreports.com/dossier/the-future-of-medical-affairs/ |
https://www.fwreports.com/dossier/orphan-drugs-us-payer-perspectives/ |
http://www.fwreports.com/dossier/evidence-matters-why-pharma-needs-to-get-serious-about-data/ |
http://www.fwreports.com/medical-affairs/ |
http://www.fwreports.com/market-access/ |
https://www.fwreports.com/dossier/smart-pharma-sales-how-digital-is-reinventing-the-process/ |
http://www.fwreports.com/dossier/real-world-data-capabilities-benchmarking-pharma-companies/ |
http://www.fwreports.com/dossier/patient-reported-outcomes-strategies-for-market-access/ |
http://www.fwreports.com/dossier/ambitions-in-health-tech-companies-step-up-the-pace/ |
https://www.fwreports.com/dossier/measuring-digital-success-in-pharma-essential-kpis/ |
https://www.fwreports.com/dossier/covid-19-implications-for-pharma-us-payer-insights/ |
http://www.fwreports.com/dossier/biomarkers-and-companion-diagnostics-payer-views/ |
http://www.fwreports.com/dossier/customer-engagement-benchmarking-leading-pharma-companies/ |
fwreports.com DNS
| A fwreports.com. 300 IN A 104.18.18.181 |
| AAAA fwreports.com. 300 IN AAAA 2606:4700::6812:13b5 |
| MX fwreports.com. 3600 IN MX 1 aspmx.l.google.com. |
| NS fwreports.com. 21600 IN NS alla.ns.cloudflare.com. |
| TXT fwreports.com. 7200 IN TXT ff4hmtu6p74dkdn22au215k4s7 |
| SOA fwreports.com. 1800 IN SOA alla.ns.cloudflare.com. dns.cloudflare.com. 2337518784 10000 2400 604800 1800 |
fwreports.com Httpheader
| Date: Tue, 14 May 2024 14:43:39 GMT |
| Content-Type: text/html; charset=utf-8 |
| Transfer-Encoding: chunked |
| Connection: keep-alive |
| Cache-Control: no-cache, no-store, must-revalidate |
| pragma: no-cache |
| expires: -1 |
| vary: Accept-Encoding |
| x-frame-options: SAMEORIGIN |
| set-cookie: .IDSDR=B575F29051BE1849AFDB0D7B4A7FE352E7D76317421B56E3AA8A2B86A719DB889D174A00725CCF7AA5738E5B0A1D3CA0F2BFDE0D5DDAD81B14586735FCE88BE7B21FA63394664F38F0FB698DC5453D9FC881A2C740FC6315B1B68056292DBEB2FF48E360DF09C9A1E362A3DF5D00077D96A6B5EFA73D4A7B7482AEFBAF86284B51756D345BBA579D628DC543CAE0D8FCA3EA1559A95A367E772D65413CA13154D170FBE7C9E39A6E9A4484ACAA9275119D29BF2B2A75ABCB252C28DD935BAB48A9081BAC739858904671BE5ED32CB195E5716BBCB5A06413B8903639A61DCF6F87D6B1FAA471530471B534B5A17D1427; expires=Wed, 15-May-2024 02:43:39 GMT; path=/; secure; HttpOnly, SessionTracker=2f7154ce-527a-4609-8b3b-763b745553e9; expires=Wed, 15-May-2024 00:00:00 GMT; path=/; secure; HttpOnly, __RequestVerificationToken=yofZtRDk-G8Pn9nB8BIvAfzaH0O6v1QekcXbB64qGMUdpA0ivlsn2HclRk3bnZOtFV5MCrtgfFYWjxQgc2Z79N7yXuG7ycMjmKdhhEoGoM81; path=/; secure; HttpOnly, __cf_bm=Z2GIYGUDrGyXxGE8OpraJI74c7X4JEriXckf5J6P74E-1715697819-1.0.1.1-ZALwqiI.tWj.N9r5heAHEt79zf55Y6iBdy3tTRwYqYb5BWdeLA8MdzpOsXSNR5PbUDR6RbyyZgcCKb2yFbTyqw; path=/; expires=Tue, 14-May-24 15:13:39 GMT; domain=.firstwordreports.com; HttpOnly; Secure; SameSite=None |
| request-context: appId=cid-v1:147608a6-b0c2-41e5-9db2-9fa1245dca5f |
| access-control-expose-headers: Request-Context |
| strict-transport-security: max-age=31536000 |
| CF-Cache-Status: DYNAMIC |
| Server: cloudflare |
| CF-RAY: 883ba96b7ca0f983-SJC |
| alt-svc: h3=":443"; ma=86400 |
fwreports.com Meta Info
| content="text/html; charset=utf-8" http-equiv="Content-Type"/ |
| content="IE=edge" http-equiv="X-UA-Compatible"/ |
| content="width=device-width" name="viewport"/ |
| content="#ffffff" name="theme-color"/ |
| content="none" name="msapplication-config" |
| content="#ffffff" name="msapplication-TileColor"/ |
| content="https://d1sskwqv60g59u.cloudfront.net/site/3/assets/img/admin/client_logo_admin-7b2b56c19e5e900e45cf7f0565ae3a30.png" name="msapplication-TileImage"/ |
fwreports.com Html To Plain Text
Whenever you visit our websites, information may be collected using cookies and similar tools to improve your user experience and to enhance the performance of the website. Closing this message means you accept the use of cookies. Search Log In Register Dossier FirstView Therapy Trends Home Research My Clippings 0 Search View Research by: Therapy Areas Cardiology Endocrinology & Diabetes Haematology Hepatology Immunology & Inflammation Infectious Diseases Neurology Oncology Respiratory All Functions/Issues Digital Health Market Access Marketing/Sales Medical Affairs Other All Stakeholders Industry Experts KOLs Treating Physicians Payers All Report Brand Dossier FirstView Therapy Trends Therapy Trends - On Demand All Recently Published Research KOL BulletinExpert views on the European approval of UCB’s Bimzelx in hidradenitis suppurativa Expert Q&A: Personalised medicine is taking centre stage, but is it sustainable? LLM Insights by ChatGPT: Wet Age-Related Macular Degeneration KOL BulletinExpert views on LEVEL-UP data for Rinvoq versus Dupixent KOL BulletinViews on the approval for earlier use of Xtandi in prostate cancer in the EU Welcome New Research (34) Upcoming Research (29) Help About FirstWord Group FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering market access, medical affairs, sales & marketing, digital health and therapy areas, FirstWord Reports provide your team with expert views and the intelligence needed to maintain a competitive edge and make sense of the constantly evolving pharmaceutical industry. Deeply impressed” Director Global eMarketing Effectiveness, Abbott ...this report has been very valuable.” Director, Biotech New Product Planning and Drug Delivery, Eli Lilly An excellent report” Knowledge Manager, Pharma and Life Sciences, PWC Very well done...[the]references are really helpful and valuable” Market Access Director, GSK Excellent” Director, Medical Affairs, AstraZeneca Insightful” Global Head GIT Collaboration & Solutions, Merck Switch to Mobile interface Privacy Policy Contact Us Terms of Use RSS © Copyright 2024 FirstWord. All Rights Reserved. All Rights...
fwreports.com Whois
Domain Name: FWREPORTS.COM Registry Domain ID: 1572126634_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.networksolutions.com Registrar URL: http://networksolutions.com Updated Date: 2023-08-14T06:57:12Z Creation Date: 2009-10-13T14:51:35Z Registry Expiry Date: 2024-10-13T14:51:35Z Registrar: Network Solutions, LLC Registrar IANA ID: 2 Registrar Abuse Contact Email: domain.operations@web.com Registrar Abuse Contact Phone: +1.8777228662 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: ALLA.NS.CLOUDFLARE.COM Name Server: WESLEY.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T20:32:48Z <<<